chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Leukocytosis, Nasal congestion, Obstructive sleep apnoea syndrome, Oedema peripheral, Oxygen saturation decreased
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge:  MD Admission Date: 10/4/2022 Discharge Date: 10/14/2022  HOSPITAL COURSE: Patient is a 78 y.o. female who presented to hospital with acute on chronic hypoxic and hypercapnic respiratory failure secondary to COPD exacerbation in the setting of acute Covid-19 infection.   COPD Exacerbation: Arrived by EMS following 3 days of increasing shortness of breath after running out of inhaler. Was found by EMS to have oxygen saturations 77% on her home oxygen. Was noted to be hypoxic and hypercapnic in ED. Attempts to improve respirations with BiPAP were unsuccessful so patient was intubated.  CXR with findings of cardiomegaly and vascular congestion. Was started on IV steroids, DuoNebs, Symbicort. Patient remained on vent for 24hrs and was successfully extubated 10/5/2022 and transferred out of ICU. Oxygen was weaned down to baseline 3.5L. Experienced a couple of night time desaturations and CO2 retention due to not wearing BiPAP when sleeping. Overnight pulse ox done 10/9: Maintains sats with mask on but drops when seal broken. Breathing slowly improved throughout admission. Steroid were weaned, will continue taper at discharge.    Covid-19 Infection: Tested positive 10/4/2022 on admission. Likely infection that triggered COPD exacerbation and respiratory failure. Was started on Remdesivir and completed 5 day course 10/4-10/8.  Was placed on steroids per COPD exacerbation. Finished 10 days of respiratory isolation prior to discharge.   GI bleed/Anemia: While intubated patient experienced bloody secretions from OG tube. Differential at that time included ulcer with concomitant use of lovenox vs trauma during ETT/OG placement. This resovled after ETT/OG were removed. Patient has chronic anemia with Hb 11 on admission. Decreased slightly during stay, but remained stable around 9.5.   Acute Exacerbation Chronic Diastolic CHF: CXR with mild pulmonary edema and small-moderate bilateral pleural effusions. Also had some mild pitting edema lower extremities. Was started on IV lasix 40mg BID, and subsequently increased to 60mg BID. Appeared to diurese well, with decrease in pitting edema. Was transitioned back to home PO 40mg Lasix BID which she tolerated well.    OSA: Infrequent use of home CPAP. Patient was instructed to use BiPAP while here in hospital as she was experiencing significant CO2 retention and decreased saturations over night. Patient should continue to utilize BiPAP at night/during naps on discharge.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: PCO2 increased, Peripheral swelling, Pleural effusion, Positive airway pressure therapy, Productive cough
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge:  MD Admission Date: 10/4/2022 Discharge Date: 10/14/2022  HOSPITAL COURSE: Patient is a 78 y.o. female who presented to hospital with acute on chronic hypoxic and hypercapnic respiratory failure secondary to COPD exacerbation in the setting of acute Covid-19 infection.   COPD Exacerbation: Arrived by EMS following 3 days of increasing shortness of breath after running out of inhaler. Was found by EMS to have oxygen saturations 77% on her home oxygen. Was noted to be hypoxic and hypercapnic in ED. Attempts to improve respirations with BiPAP were unsuccessful so patient was intubated.  CXR with findings of cardiomegaly and vascular congestion. Was started on IV steroids, DuoNebs, Symbicort. Patient remained on vent for 24hrs and was successfully extubated 10/5/2022 and transferred out of ICU. Oxygen was weaned down to baseline 3.5L. Experienced a couple of night time desaturations and CO2 retention due to not wearing BiPAP when sleeping. Overnight pulse ox done 10/9: Maintains sats with mask on but drops when seal broken. Breathing slowly improved throughout admission. Steroid were weaned, will continue taper at discharge.    Covid-19 Infection: Tested positive 10/4/2022 on admission. Likely infection that triggered COPD exacerbation and respiratory failure. Was started on Remdesivir and completed 5 day course 10/4-10/8.  Was placed on steroids per COPD exacerbation. Finished 10 days of respiratory isolation prior to discharge.   GI bleed/Anemia: While intubated patient experienced bloody secretions from OG tube. Differential at that time included ulcer with concomitant use of lovenox vs trauma during ETT/OG placement. This resovled after ETT/OG were removed. Patient has chronic anemia with Hb 11 on admission. Decreased slightly during stay, but remained stable around 9.5.   Acute Exacerbation Chronic Diastolic CHF: CXR with mild pulmonary edema and small-moderate bilateral pleural effusions. Also had some mild pitting edema lower extremities. Was started on IV lasix 40mg BID, and subsequently increased to 60mg BID. Appeared to diurese well, with decrease in pitting edema. Was transitioned back to home PO 40mg Lasix BID which she tolerated well.    OSA: Infrequent use of home CPAP. Patient was instructed to use BiPAP while here in hospital as she was experiencing significant CO2 retention and decreased saturations over night. Patient should continue to utilize BiPAP at night/during naps on discharge.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pulmonary function test abnormal, Pulmonary oedema, Respiratory acidosis, Respiratory failure, Respiratory syncytial virus test negative
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge:  MD Admission Date: 10/4/2022 Discharge Date: 10/14/2022  HOSPITAL COURSE: Patient is a 78 y.o. female who presented to hospital with acute on chronic hypoxic and hypercapnic respiratory failure secondary to COPD exacerbation in the setting of acute Covid-19 infection.   COPD Exacerbation: Arrived by EMS following 3 days of increasing shortness of breath after running out of inhaler. Was found by EMS to have oxygen saturations 77% on her home oxygen. Was noted to be hypoxic and hypercapnic in ED. Attempts to improve respirations with BiPAP were unsuccessful so patient was intubated.  CXR with findings of cardiomegaly and vascular congestion. Was started on IV steroids, DuoNebs, Symbicort. Patient remained on vent for 24hrs and was successfully extubated 10/5/2022 and transferred out of ICU. Oxygen was weaned down to baseline 3.5L. Experienced a couple of night time desaturations and CO2 retention due to not wearing BiPAP when sleeping. Overnight pulse ox done 10/9: Maintains sats with mask on but drops when seal broken. Breathing slowly improved throughout admission. Steroid were weaned, will continue taper at discharge.    Covid-19 Infection: Tested positive 10/4/2022 on admission. Likely infection that triggered COPD exacerbation and respiratory failure. Was started on Remdesivir and completed 5 day course 10/4-10/8.  Was placed on steroids per COPD exacerbation. Finished 10 days of respiratory isolation prior to discharge.   GI bleed/Anemia: While intubated patient experienced bloody secretions from OG tube. Differential at that time included ulcer with concomitant use of lovenox vs trauma during ETT/OG placement. This resovled after ETT/OG were removed. Patient has chronic anemia with Hb 11 on admission. Decreased slightly during stay, but remained stable around 9.5.   Acute Exacerbation Chronic Diastolic CHF: CXR with mild pulmonary edema and small-moderate bilateral pleural effusions. Also had some mild pitting edema lower extremities. Was started on IV lasix 40mg BID, and subsequently increased to 60mg BID. Appeared to diurese well, with decrease in pitting edema. Was transitioned back to home PO 40mg Lasix BID which she tolerated well.    OSA: Infrequent use of home CPAP. Patient was instructed to use BiPAP while here in hospital as she was experiencing significant CO2 retention and decreased saturations over night. Patient should continue to utilize BiPAP at night/during naps on discharge.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test negative, SARS-CoV-2 test positive, Tachycardia, Tachypnoea, Therapeutic product ineffective
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge:  MD Admission Date: 10/4/2022 Discharge Date: 10/14/2022  HOSPITAL COURSE: Patient is a 78 y.o. female who presented to hospital with acute on chronic hypoxic and hypercapnic respiratory failure secondary to COPD exacerbation in the setting of acute Covid-19 infection.   COPD Exacerbation: Arrived by EMS following 3 days of increasing shortness of breath after running out of inhaler. Was found by EMS to have oxygen saturations 77% on her home oxygen. Was noted to be hypoxic and hypercapnic in ED. Attempts to improve respirations with BiPAP were unsuccessful so patient was intubated.  CXR with findings of cardiomegaly and vascular congestion. Was started on IV steroids, DuoNebs, Symbicort. Patient remained on vent for 24hrs and was successfully extubated 10/5/2022 and transferred out of ICU. Oxygen was weaned down to baseline 3.5L. Experienced a couple of night time desaturations and CO2 retention due to not wearing BiPAP when sleeping. Overnight pulse ox done 10/9: Maintains sats with mask on but drops when seal broken. Breathing slowly improved throughout admission. Steroid were weaned, will continue taper at discharge.    Covid-19 Infection: Tested positive 10/4/2022 on admission. Likely infection that triggered COPD exacerbation and respiratory failure. Was started on Remdesivir and completed 5 day course 10/4-10/8.  Was placed on steroids per COPD exacerbation. Finished 10 days of respiratory isolation prior to discharge.   GI bleed/Anemia: While intubated patient experienced bloody secretions from OG tube. Differential at that time included ulcer with concomitant use of lovenox vs trauma during ETT/OG placement. This resovled after ETT/OG were removed. Patient has chronic anemia with Hb 11 on admission. Decreased slightly during stay, but remained stable around 9.5.   Acute Exacerbation Chronic Diastolic CHF: CXR with mild pulmonary edema and small-moderate bilateral pleural effusions. Also had some mild pitting edema lower extremities. Was started on IV lasix 40mg BID, and subsequently increased to 60mg BID. Appeared to diurese well, with decrease in pitting edema. Was transitioned back to home PO 40mg Lasix BID which she tolerated well.    OSA: Infrequent use of home CPAP. Patient was instructed to use BiPAP while here in hospital as she was experiencing significant CO2 retention and decreased saturations over night. Patient should continue to utilize BiPAP at night/during naps on discharge.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tremor, White blood cell count increased
Clinical narrative: Discharge Provider: DO Primary Care Provider at Discharge:  MD Admission Date: 10/4/2022 Discharge Date: 10/14/2022  HOSPITAL COURSE: Patient is a 78 y.o. female who presented to hospital with acute on chronic hypoxic and hypercapnic respiratory failure secondary to COPD exacerbation in the setting of acute Covid-19 infection.   COPD Exacerbation: Arrived by EMS following 3 days of increasing shortness of breath after running out of inhaler. Was found by EMS to have oxygen saturations 77% on her home oxygen. Was noted to be hypoxic and hypercapnic in ED. Attempts to improve respirations with BiPAP were unsuccessful so patient was intubated.  CXR with findings of cardiomegaly and vascular congestion. Was started on IV steroids, DuoNebs, Symbicort. Patient remained on vent for 24hrs and was successfully extubated 10/5/2022 and transferred out of ICU. Oxygen was weaned down to baseline 3.5L. Experienced a couple of night time desaturations and CO2 retention due to not wearing BiPAP when sleeping. Overnight pulse ox done 10/9: Maintains sats with mask on but drops when seal broken. Breathing slowly improved throughout admission. Steroid were weaned, will continue taper at discharge.    Covid-19 Infection: Tested positive 10/4/2022 on admission. Likely infection that triggered COPD exacerbation and respiratory failure. Was started on Remdesivir and completed 5 day course 10/4-10/8.  Was placed on steroids per COPD exacerbation. Finished 10 days of respiratory isolation prior to discharge.   GI bleed/Anemia: While intubated patient experienced bloody secretions from OG tube. Differential at that time included ulcer with concomitant use of lovenox vs trauma during ETT/OG placement. This resovled after ETT/OG were removed. Patient has chronic anemia with Hb 11 on admission. Decreased slightly during stay, but remained stable around 9.5.   Acute Exacerbation Chronic Diastolic CHF: CXR with mild pulmonary edema and small-moderate bilateral pleural effusions. Also had some mild pitting edema lower extremities. Was started on IV lasix 40mg BID, and subsequently increased to 60mg BID. Appeared to diurese well, with decrease in pitting edema. Was transitioned back to home PO 40mg Lasix BID which she tolerated well.    OSA: Infrequent use of home CPAP. Patient was instructed to use BiPAP while here in hospital as she was experiencing significant CO2 retention and decreased saturations over night. Patient should continue to utilize BiPAP at night/during naps on discharge.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Received previous booster monovalent vaccine instead of the new bivalent booster, no adverse reaction noted the first 15 min of observation.
Age: 55.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: On 9/28/2022, I tested positive for COVID-19 via a Binax hometest.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient received Monovalent instead of Bivalent booster
Age: 42.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cardiac function test abnormal, Condition aggravated, Dizziness, Electrocardiogram normal, Fatigue
Clinical narrative: In the morning of the day following the COVID vaccine, I experienced symptoms that have since been diagnosed by a cardiologist as POTS--postural orthostatic tachycardia syndrome. My heart rate would increase significantly upon standing upright, and I was dizzy and exhausted when walking or moving about the house. This happened to me with my other Moderna shots as well, and intermittently over the last year. It's likely that I have had these symptoms with illness in a milder degree on an intermittent basis for many years, but they were debilitating enough that I tracked my heart rate during these instances. After vaccination, it would rise from the 60s/70s to 130-140 upon standing or walking throughout the house. The intensity subsided within 48 hours of vaccination, but I have had recurring instances in the month since then and was referred to a cardiologist this month, when I was diagnosed with POTS. I don't know think the vaccine caused this, but it might have exacerbated an underlying condition.
Age: 42.0
Sex: F
Vaccine: COVID19-2
Symptoms: Heart rate increased, Postural orthostatic tachycardia syndrome
Clinical narrative: In the morning of the day following the COVID vaccine, I experienced symptoms that have since been diagnosed by a cardiologist as POTS--postural orthostatic tachycardia syndrome. My heart rate would increase significantly upon standing upright, and I was dizzy and exhausted when walking or moving about the house. This happened to me with my other Moderna shots as well, and intermittently over the last year. It's likely that I have had these symptoms with illness in a milder degree on an intermittent basis for many years, but they were debilitating enough that I tracked my heart rate during these instances. After vaccination, it would rise from the 60s/70s to 130-140 upon standing or walking throughout the house. The intensity subsided within 48 hours of vaccination, but I have had recurring instances in the month since then and was referred to a cardiologist this month, when I was diagnosed with POTS. I don't know think the vaccine caused this, but it might have exacerbated an underlying condition.
Age: 69.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Contusion, Joint swelling
Clinical narrative: Patient called on 10/14/2022 to report a reaction to the flu vaccine on 10/7/2022. Patient received a vaccine at a Flu Clinic around 11:50am and starting having aching and swelling in the left wrist around 12:05pm that lasted less than 36 hours. Patient stated her wrist bruised after the swelling and is still a little yellow today.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Received previous booster monovalent vaccine instead of the new bivalent booster, no adverse reaction noted the first 15 min of observation.
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP, FLU4, HIBV, PNC13
Symptoms: Infant irritability, Product administered to patient of inappropriate age
Clinical narrative: influenza vaccine given at 4 months of age along with routine vaccines. child did run fever of 100 and was very fussy.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient received Monovalent instead of Bivalent booster
Age: 18.0
Sex: F
Vaccine: UNK
Symptoms: Abdominal discomfort, Abdominal distension, Injection site pain, Malaise
Clinical narrative: Pain injection site.  In morning, abdominal bloating/distention and abdominal discomfort. Feeling unwell.
Age: 46.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Ear pain, Facial pain, Herpes simplex test, Lip blister, Oropharyngeal pain
Clinical narrative: I noticed that I got a blister on my lip. The next day I developed pain on the left side of my face under my eye, ear, and jaw line. I had a sore throat and another blister on my tongue. I went into the urgent care 10/13/2022 and the doctor thought I might have either singles, or just bad allergies. I went home and took a BENADRYL and today I am feeling so much better. I still have pain behind my ear, my face is starting to feel better.
Age: 46.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Pain in jaw, Tongue blistering
Clinical narrative: I noticed that I got a blister on my lip. The next day I developed pain on the left side of my face under my eye, ear, and jaw line. I had a sore throat and another blister on my tongue. I went into the urgent care 10/13/2022 and the doctor thought I might have either singles, or just bad allergies. I went home and took a BENADRYL and today I am feeling so much better. I still have pain behind my ear, my face is starting to feel better.
Age: 11.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: PARENT REPORTED NO SIDE EFFECTS AS OF 10/11/22
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient received Monovalent instead of Bivalent booster
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Received previous booster monovalent vaccine instead of the new bivalent booster, no adverse reaction noted the first 15 min of observation.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Head discomfort, Influenza virus test negative, Loss of personal independence in daily activities
Clinical narrative: I received my second Moderna booster on 7/14/2022. On 8/20/2022, I woke up at 6 AM congested and achy all over. I also had nausea and vomiting, plus a cough. On 8/21/2022, I went to an urgent care clinic to get tested for COVID-19. I was tested for both COVID-19 and the flu, and the results on both were negative. I was given TESSALON for my cough and told to go home and isolate, as I had yet to get the results of the COVID-19 test. Even though I got a negative test result, I decided to self-isolate for the rest of the month. I felt better around 9/1/2022 and resumed my regular routine. On the morning of 9/8/2022, I woke up with head congestion, cough, and body aches. I took a home test and got a positive result. I had a telehealth visit with my PA that day, and I was prescribed PAXLOVID. I picked it up on 9/9/2022 and began taking it that day. I also began self-isolating again. I stayed at home until about 9/27/2022 and I then resumed my normal activities.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Respiratory tract congestion, SARS-CoV-2 test positive, Vomiting
Clinical narrative: I received my second Moderna booster on 7/14/2022. On 8/20/2022, I woke up at 6 AM congested and achy all over. I also had nausea and vomiting, plus a cough. On 8/21/2022, I went to an urgent care clinic to get tested for COVID-19. I was tested for both COVID-19 and the flu, and the results on both were negative. I was given TESSALON for my cough and told to go home and isolate, as I had yet to get the results of the COVID-19 test. Even though I got a negative test result, I decided to self-isolate for the rest of the month. I felt better around 9/1/2022 and resumed my regular routine. On the morning of 9/8/2022, I woke up with head congestion, cough, and body aches. I took a home test and got a positive result. I had a telehealth visit with my PA that day, and I was prescribed PAXLOVID. I picked it up on 9/9/2022 and began taking it that day. I also began self-isolating again. I stayed at home until about 9/27/2022 and I then resumed my normal activities.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient received Monovalent instead of Bivalent Booster
Age: 33.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Erythema, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: I received the bivalent covid booster on 10/12/22 at the local medical center..   12-18 hrs post vaccine, I began to have common side effects: chills, low grade fever, pain at injection site, for which I took ibuprofen. 36-48 I had swelling, redness and pain at the injection site and red, hot and swollen, painful axillary lymph nodes, for which I took ibuprofen and iced my arm 72hrs-lymph nodes are better but injection site is red, hot, and swollen to the size of a softball.    Today at 72 hours post vaccine, I went to see Specialists in employee health regarding my symptoms. One specialist gave me an ice pack, reassured me to continue taking ibuprofen, and instructed me to contact you with this information.
Age: 33.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site warmth, Lymphadenopathy, Pyrexia, Skin warm
Clinical narrative: I received the bivalent covid booster on 10/12/22 at the local medical center..   12-18 hrs post vaccine, I began to have common side effects: chills, low grade fever, pain at injection site, for which I took ibuprofen. 36-48 I had swelling, redness and pain at the injection site and red, hot and swollen, painful axillary lymph nodes, for which I took ibuprofen and iced my arm 72hrs-lymph nodes are better but injection site is red, hot, and swollen to the size of a softball.    Today at 72 hours post vaccine, I went to see Specialists in employee health regarding my symptoms. One specialist gave me an ice pack, reassured me to continue taking ibuprofen, and instructed me to contact you with this information.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood pressure increased, Chest discomfort, Computerised tomogram, Condition aggravated
Clinical narrative: 7/1/2022 Received COVID booster. Shearing cold pain across clavicle, through joint, down arm upon injection. Injection was placed 1? below shoulder. Pain immediately radiated to clavicle. Unable to sleep due to high pain level; since then, unable to dress myself, brush my own hair or teeth. Diagnosed with frozen shoulder, remain in PT as of 10/14/2022.  Migraine Started morning of 7/2/2022. Have experienced migraine every day since.  Ongoing issues encountered: Tremors, pain to neck/back of head, confusion, hallucinations, slurred/slow speech, Parkinson?s-like symptoms (significant major tremors throughout body), nausea, chest pressure, shortness of breath, spikes in blood pressure. I have fallen three times, two ER visits, one for dizziness/head pain and the second for chest pressure and significant sudden blood pressure elevation (188/114).  Was terminated from new job due to inability to perform nursing job related to the response/reaction I am having.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Dizziness, Dysarthria, Dyspnoea, Electrocardiogram
Clinical narrative: 7/1/2022 Received COVID booster. Shearing cold pain across clavicle, through joint, down arm upon injection. Injection was placed 1? below shoulder. Pain immediately radiated to clavicle. Unable to sleep due to high pain level; since then, unable to dress myself, brush my own hair or teeth. Diagnosed with frozen shoulder, remain in PT as of 10/14/2022.  Migraine Started morning of 7/2/2022. Have experienced migraine every day since.  Ongoing issues encountered: Tremors, pain to neck/back of head, confusion, hallucinations, slurred/slow speech, Parkinson?s-like symptoms (significant major tremors throughout body), nausea, chest pressure, shortness of breath, spikes in blood pressure. I have fallen three times, two ER visits, one for dizziness/head pain and the second for chest pressure and significant sudden blood pressure elevation (188/114).  Was terminated from new job due to inability to perform nursing job related to the response/reaction I am having.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Electroencephalogram, Fall, Hallucination, Headache, Impaired work ability
Clinical narrative: 7/1/2022 Received COVID booster. Shearing cold pain across clavicle, through joint, down arm upon injection. Injection was placed 1? below shoulder. Pain immediately radiated to clavicle. Unable to sleep due to high pain level; since then, unable to dress myself, brush my own hair or teeth. Diagnosed with frozen shoulder, remain in PT as of 10/14/2022.  Migraine Started morning of 7/2/2022. Have experienced migraine every day since.  Ongoing issues encountered: Tremors, pain to neck/back of head, confusion, hallucinations, slurred/slow speech, Parkinson?s-like symptoms (significant major tremors throughout body), nausea, chest pressure, shortness of breath, spikes in blood pressure. I have fallen three times, two ER visits, one for dizziness/head pain and the second for chest pressure and significant sudden blood pressure elevation (188/114).  Was terminated from new job due to inability to perform nursing job related to the response/reaction I am having.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Insomnia, Laboratory test, Loss of employment, Loss of personal independence in daily activities
Clinical narrative: 7/1/2022 Received COVID booster. Shearing cold pain across clavicle, through joint, down arm upon injection. Injection was placed 1? below shoulder. Pain immediately radiated to clavicle. Unable to sleep due to high pain level; since then, unable to dress myself, brush my own hair or teeth. Diagnosed with frozen shoulder, remain in PT as of 10/14/2022.  Migraine Started morning of 7/2/2022. Have experienced migraine every day since.  Ongoing issues encountered: Tremors, pain to neck/back of head, confusion, hallucinations, slurred/slow speech, Parkinson?s-like symptoms (significant major tremors throughout body), nausea, chest pressure, shortness of breath, spikes in blood pressure. I have fallen three times, two ER visits, one for dizziness/head pain and the second for chest pressure and significant sudden blood pressure elevation (188/114).  Was terminated from new job due to inability to perform nursing job related to the response/reaction I am having.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging, Migraine, Nausea, Neck pain, Pain
Clinical narrative: 7/1/2022 Received COVID booster. Shearing cold pain across clavicle, through joint, down arm upon injection. Injection was placed 1? below shoulder. Pain immediately radiated to clavicle. Unable to sleep due to high pain level; since then, unable to dress myself, brush my own hair or teeth. Diagnosed with frozen shoulder, remain in PT as of 10/14/2022.  Migraine Started morning of 7/2/2022. Have experienced migraine every day since.  Ongoing issues encountered: Tremors, pain to neck/back of head, confusion, hallucinations, slurred/slow speech, Parkinson?s-like symptoms (significant major tremors throughout body), nausea, chest pressure, shortness of breath, spikes in blood pressure. I have fallen three times, two ER visits, one for dizziness/head pain and the second for chest pressure and significant sudden blood pressure elevation (188/114).  Was terminated from new job due to inability to perform nursing job related to the response/reaction I am having.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Periarthritis, Slow speech, Tremor, X-ray
Clinical narrative: 7/1/2022 Received COVID booster. Shearing cold pain across clavicle, through joint, down arm upon injection. Injection was placed 1? below shoulder. Pain immediately radiated to clavicle. Unable to sleep due to high pain level; since then, unable to dress myself, brush my own hair or teeth. Diagnosed with frozen shoulder, remain in PT as of 10/14/2022.  Migraine Started morning of 7/2/2022. Have experienced migraine every day since.  Ongoing issues encountered: Tremors, pain to neck/back of head, confusion, hallucinations, slurred/slow speech, Parkinson?s-like symptoms (significant major tremors throughout body), nausea, chest pressure, shortness of breath, spikes in blood pressure. I have fallen three times, two ER visits, one for dizziness/head pain and the second for chest pressure and significant sudden blood pressure elevation (188/114).  Was terminated from new job due to inability to perform nursing job related to the response/reaction I am having.
Age: 15.0
Sex: M
Vaccine: UNK
Symptoms: Immediate post-injection reaction, Injection site discomfort, Injection site pain
Clinical narrative: Pain during injection. Immediate injection site pain, lasting all evening. Injection site discomfort.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient received Monovalent instead of Bivalent booster
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Blister, Herpes zoster, Pain, Rash, Sensitive skin
Clinical narrative: Rashes developed on chest one day after the Modern bivalent Covid booster shot. Doctor confirmed shingles due to reduced immunity.  All symptoms of shingles developed after the doctor visit including clusters of rashes on one side of upper body, painful blisters filled with liquid, sensitive skin, stabbing pain etc. Now on medication, Valacyclovir 1 gm, for the fourth day.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient received Monovalent instead of Bivalent booster
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Psoriasis, Skin disorder
Clinical narrative: Approximately one month after receiving my second dose I broke out with a horrible case of Psorisis covered from head to toe with gashes on both feet and hands
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Headache, Malaise
Clinical narrative: 08/30/2022, I began to experience a scratchy throat. I tested positive two days later. I had sore throat, muscle aches, headache, fever, malaise, cough, lasting four weeks.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive, Throat irritation
Clinical narrative: 08/30/2022, I began to experience a scratchy throat. I tested positive two days later. I had sore throat, muscle aches, headache, fever, malaise, cough, lasting four weeks.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Pt received Monovalent instead of Bivalent booster
Age: 52.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Atelectasis, Bacterial test positive, Blood glucose increased, Blood lactic acid, Bronchitis
Clinical narrative: Discharge Provider: Unknown * Primary Care Provider: Private MD Admission Date: 10/1/2022 Discharge Date: Oct 13, 2022  PRESENTING PROBLEM: Fournier's gangrene [N49.3] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 52 y.o. male who present on 10/1 with fevers, chills, fatigue, and scrotal abscess. Pt. has a PMH of COPD, DM2, tobacco abuse, DVT no longer anticoagulated. Pt. reports for 1 week he had SOB and increased wheezing. He felt feverish on 9/28 and presented to his PCP office where he was diagnosed with a mild COPD exacerbation secondary to bronchitis. He was started on a prednisone taper and azithromycin. He also notes he had a small cyst on the left of his scrotum that he was able to get a small amount of pus out of. Over 2-3 days, it greatly increased in size with surrounding erythema and increasing pain.    Upon evaluation in the ED, labs with elevated glucose levels, WBC 23, Lactic acid 4.3 -> 0.8. Chest x-ray with mild basilar scarring or atelectasis. Scrotal U/S with right inguinal hernia, mild left variocele. CT abdomen pelvis with concerns for fournier's gangrene. He tested positive for COVID 19. He was admitted for further medical management of sepsis due to fournier's gangrene.   Urology was consulted and performed scrotal exploration, cystoscopy, left ureteral stent placement, scrotal resection and debridement on 10/01. Plastic surgery, Wound and Infectious disease were consulted. He was continue on IV antibiotics. He received ongoing wound care. He received analgesics as needed. Tissue cultures grew strep agalactiae as well as prevotella.  Eventually, Infectious Disease recommended 14 days of total therapy and he was able to switch to oral antibiotics in form of cefadroxil and metronidazole with plan for antibiotics through 10/15.   He received decadron and remdesivir for treatment of COVID 19. Oxygen was weaned as able he was eventually able to transition to room air with cessation of dexamethasone.       Assisted with management of blood sugars with insulin.   The patient had remain medically stable for several days and came out of enhanced isolation precautions. He was able to be transition to subacute rehab on 10/13/2022.  He will need outpatient follow up with Urology for outpatient left ureteroscopy in 3-4 weeks.
Age: 52.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, Chest X-ray abnormal, Chills, Chronic obstructive pulmonary disease, Computerised tomogram abdomen abnormal
Clinical narrative: Discharge Provider: Unknown * Primary Care Provider: Private MD Admission Date: 10/1/2022 Discharge Date: Oct 13, 2022  PRESENTING PROBLEM: Fournier's gangrene [N49.3] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 52 y.o. male who present on 10/1 with fevers, chills, fatigue, and scrotal abscess. Pt. has a PMH of COPD, DM2, tobacco abuse, DVT no longer anticoagulated. Pt. reports for 1 week he had SOB and increased wheezing. He felt feverish on 9/28 and presented to his PCP office where he was diagnosed with a mild COPD exacerbation secondary to bronchitis. He was started on a prednisone taper and azithromycin. He also notes he had a small cyst on the left of his scrotum that he was able to get a small amount of pus out of. Over 2-3 days, it greatly increased in size with surrounding erythema and increasing pain.    Upon evaluation in the ED, labs with elevated glucose levels, WBC 23, Lactic acid 4.3 -> 0.8. Chest x-ray with mild basilar scarring or atelectasis. Scrotal U/S with right inguinal hernia, mild left variocele. CT abdomen pelvis with concerns for fournier's gangrene. He tested positive for COVID 19. He was admitted for further medical management of sepsis due to fournier's gangrene.   Urology was consulted and performed scrotal exploration, cystoscopy, left ureteral stent placement, scrotal resection and debridement on 10/01. Plastic surgery, Wound and Infectious disease were consulted. He was continue on IV antibiotics. He received ongoing wound care. He received analgesics as needed. Tissue cultures grew strep agalactiae as well as prevotella.  Eventually, Infectious Disease recommended 14 days of total therapy and he was able to switch to oral antibiotics in form of cefadroxil and metronidazole with plan for antibiotics through 10/15.   He received decadron and remdesivir for treatment of COVID 19. Oxygen was weaned as able he was eventually able to transition to room air with cessation of dexamethasone.       Assisted with management of blood sugars with insulin.   The patient had remain medically stable for several days and came out of enhanced isolation precautions. He was able to be transition to subacute rehab on 10/13/2022.  He will need outpatient follow up with Urology for outpatient left ureteroscopy in 3-4 weeks.
Age: 52.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Condition aggravated, Culture tissue specimen positive, Cystoscopy abnormal, Debridement, Dyspnoea
Clinical narrative: Discharge Provider: Unknown * Primary Care Provider: Private MD Admission Date: 10/1/2022 Discharge Date: Oct 13, 2022  PRESENTING PROBLEM: Fournier's gangrene [N49.3] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 52 y.o. male who present on 10/1 with fevers, chills, fatigue, and scrotal abscess. Pt. has a PMH of COPD, DM2, tobacco abuse, DVT no longer anticoagulated. Pt. reports for 1 week he had SOB and increased wheezing. He felt feverish on 9/28 and presented to his PCP office where he was diagnosed with a mild COPD exacerbation secondary to bronchitis. He was started on a prednisone taper and azithromycin. He also notes he had a small cyst on the left of his scrotum that he was able to get a small amount of pus out of. Over 2-3 days, it greatly increased in size with surrounding erythema and increasing pain.    Upon evaluation in the ED, labs with elevated glucose levels, WBC 23, Lactic acid 4.3 -> 0.8. Chest x-ray with mild basilar scarring or atelectasis. Scrotal U/S with right inguinal hernia, mild left variocele. CT abdomen pelvis with concerns for fournier's gangrene. He tested positive for COVID 19. He was admitted for further medical management of sepsis due to fournier's gangrene.   Urology was consulted and performed scrotal exploration, cystoscopy, left ureteral stent placement, scrotal resection and debridement on 10/01. Plastic surgery, Wound and Infectious disease were consulted. He was continue on IV antibiotics. He received ongoing wound care. He received analgesics as needed. Tissue cultures grew strep agalactiae as well as prevotella.  Eventually, Infectious Disease recommended 14 days of total therapy and he was able to switch to oral antibiotics in form of cefadroxil and metronidazole with plan for antibiotics through 10/15.   He received decadron and remdesivir for treatment of COVID 19. Oxygen was weaned as able he was eventually able to transition to room air with cessation of dexamethasone.       Assisted with management of blood sugars with insulin.   The patient had remain medically stable for several days and came out of enhanced isolation precautions. He was able to be transition to subacute rehab on 10/13/2022.  He will need outpatient follow up with Urology for outpatient left ureteroscopy in 3-4 weeks.
Age: 52.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Erythema, Fatigue, Fournier's gangrene, Inguinal hernia, Insulin therapy
Clinical narrative: Discharge Provider: Unknown * Primary Care Provider: Private MD Admission Date: 10/1/2022 Discharge Date: Oct 13, 2022  PRESENTING PROBLEM: Fournier's gangrene [N49.3] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 52 y.o. male who present on 10/1 with fevers, chills, fatigue, and scrotal abscess. Pt. has a PMH of COPD, DM2, tobacco abuse, DVT no longer anticoagulated. Pt. reports for 1 week he had SOB and increased wheezing. He felt feverish on 9/28 and presented to his PCP office where he was diagnosed with a mild COPD exacerbation secondary to bronchitis. He was started on a prednisone taper and azithromycin. He also notes he had a small cyst on the left of his scrotum that he was able to get a small amount of pus out of. Over 2-3 days, it greatly increased in size with surrounding erythema and increasing pain.    Upon evaluation in the ED, labs with elevated glucose levels, WBC 23, Lactic acid 4.3 -> 0.8. Chest x-ray with mild basilar scarring or atelectasis. Scrotal U/S with right inguinal hernia, mild left variocele. CT abdomen pelvis with concerns for fournier's gangrene. He tested positive for COVID 19. He was admitted for further medical management of sepsis due to fournier's gangrene.   Urology was consulted and performed scrotal exploration, cystoscopy, left ureteral stent placement, scrotal resection and debridement on 10/01. Plastic surgery, Wound and Infectious disease were consulted. He was continue on IV antibiotics. He received ongoing wound care. He received analgesics as needed. Tissue cultures grew strep agalactiae as well as prevotella.  Eventually, Infectious Disease recommended 14 days of total therapy and he was able to switch to oral antibiotics in form of cefadroxil and metronidazole with plan for antibiotics through 10/15.   He received decadron and remdesivir for treatment of COVID 19. Oxygen was weaned as able he was eventually able to transition to room air with cessation of dexamethasone.       Assisted with management of blood sugars with insulin.   The patient had remain medically stable for several days and came out of enhanced isolation precautions. He was able to be transition to subacute rehab on 10/13/2022.  He will need outpatient follow up with Urology for outpatient left ureteroscopy in 3-4 weeks.
Age: 52.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Pain, Pulmonary fibrosis, Purulent discharge, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Discharge Provider: Unknown * Primary Care Provider: Private MD Admission Date: 10/1/2022 Discharge Date: Oct 13, 2022  PRESENTING PROBLEM: Fournier's gangrene [N49.3] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 52 y.o. male who present on 10/1 with fevers, chills, fatigue, and scrotal abscess. Pt. has a PMH of COPD, DM2, tobacco abuse, DVT no longer anticoagulated. Pt. reports for 1 week he had SOB and increased wheezing. He felt feverish on 9/28 and presented to his PCP office where he was diagnosed with a mild COPD exacerbation secondary to bronchitis. He was started on a prednisone taper and azithromycin. He also notes he had a small cyst on the left of his scrotum that he was able to get a small amount of pus out of. Over 2-3 days, it greatly increased in size with surrounding erythema and increasing pain.    Upon evaluation in the ED, labs with elevated glucose levels, WBC 23, Lactic acid 4.3 -> 0.8. Chest x-ray with mild basilar scarring or atelectasis. Scrotal U/S with right inguinal hernia, mild left variocele. CT abdomen pelvis with concerns for fournier's gangrene. He tested positive for COVID 19. He was admitted for further medical management of sepsis due to fournier's gangrene.   Urology was consulted and performed scrotal exploration, cystoscopy, left ureteral stent placement, scrotal resection and debridement on 10/01. Plastic surgery, Wound and Infectious disease were consulted. He was continue on IV antibiotics. He received ongoing wound care. He received analgesics as needed. Tissue cultures grew strep agalactiae as well as prevotella.  Eventually, Infectious Disease recommended 14 days of total therapy and he was able to switch to oral antibiotics in form of cefadroxil and metronidazole with plan for antibiotics through 10/15.   He received decadron and remdesivir for treatment of COVID 19. Oxygen was weaned as able he was eventually able to transition to room air with cessation of dexamethasone.       Assisted with management of blood sugars with insulin.   The patient had remain medically stable for several days and came out of enhanced isolation precautions. He was able to be transition to subacute rehab on 10/13/2022.  He will need outpatient follow up with Urology for outpatient left ureteroscopy in 3-4 weeks.
Age: 52.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Scrotal abscess, Scrotal cyst, Scrotal exploration, Scrotal operation, Sepsis
Clinical narrative: Discharge Provider: Unknown * Primary Care Provider: Private MD Admission Date: 10/1/2022 Discharge Date: Oct 13, 2022  PRESENTING PROBLEM: Fournier's gangrene [N49.3] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 52 y.o. male who present on 10/1 with fevers, chills, fatigue, and scrotal abscess. Pt. has a PMH of COPD, DM2, tobacco abuse, DVT no longer anticoagulated. Pt. reports for 1 week he had SOB and increased wheezing. He felt feverish on 9/28 and presented to his PCP office where he was diagnosed with a mild COPD exacerbation secondary to bronchitis. He was started on a prednisone taper and azithromycin. He also notes he had a small cyst on the left of his scrotum that he was able to get a small amount of pus out of. Over 2-3 days, it greatly increased in size with surrounding erythema and increasing pain.    Upon evaluation in the ED, labs with elevated glucose levels, WBC 23, Lactic acid 4.3 -> 0.8. Chest x-ray with mild basilar scarring or atelectasis. Scrotal U/S with right inguinal hernia, mild left variocele. CT abdomen pelvis with concerns for fournier's gangrene. He tested positive for COVID 19. He was admitted for further medical management of sepsis due to fournier's gangrene.   Urology was consulted and performed scrotal exploration, cystoscopy, left ureteral stent placement, scrotal resection and debridement on 10/01. Plastic surgery, Wound and Infectious disease were consulted. He was continue on IV antibiotics. He received ongoing wound care. He received analgesics as needed. Tissue cultures grew strep agalactiae as well as prevotella.  Eventually, Infectious Disease recommended 14 days of total therapy and he was able to switch to oral antibiotics in form of cefadroxil and metronidazole with plan for antibiotics through 10/15.   He received decadron and remdesivir for treatment of COVID 19. Oxygen was weaned as able he was eventually able to transition to room air with cessation of dexamethasone.       Assisted with management of blood sugars with insulin.   The patient had remain medically stable for several days and came out of enhanced isolation precautions. He was able to be transition to subacute rehab on 10/13/2022.  He will need outpatient follow up with Urology for outpatient left ureteroscopy in 3-4 weeks.